Can multidrug-resistant microbes trap in molecular glue?


 Can multi drug-resistant microbes trap in molecular glue?

Multiple drug resistance (MDR), is the microorganisms that are resistant to an antimicrobial drug. These microbes are most threatening to public health. MDR microbes can resist multiple antibiotics; other types include MDR bacteria, viruses, fungi, and parasites (resistant to multiple antibacterial, antifungal, antiviral, and anti-parasitic drugs of a wide chemical variety).
Around the world bacteria are evolving new approaches that help to render them resistant to antibiotics, resulting in a growing number of patients dying from untreatable infections. Scientists are now focusing to discover new medicines soon, otherwise the post-antibiotic era may be upon us, effectively pushing human healthcare back to the 1940s.The most causative class of bacteria are 'Gram-negative bacteria', which include the most common & well-known species E. coli, are causing major problems in our hospitals.


The problem is that microorganisms have lasted for thousands of years by their capability to adapt to antimicrobial agents which takes place due to spontaneous mutation or by DNA transfer. This process allows some bacteria to face the action of certain antibiotics, rendering the antibiotics ineffective. Most antibiotics that we know today work according to only a few mechanisms of action and so when a bacterium develops tolerant to one drug, it often becomes tolerant of the whole family of drug type. The only solution to deal with the situation is to develop an entirely new class of drugs that share no structural or mechanistic similarities with the existing antibiotics.
These drugs penetrate bacterial cells and induce a process called protein aggregation. In this process, the bacterial proteins that normally carry out essential functions for the bacteria - such as digesting their food,  clump together and can no longer carry out their work which affects many proteins in the bacterial cell all at once, the bacteria rapidly succumb and die.

For more details : https://bacteriology.infectiousconferences.com/ 


Comments

Post a Comment

Popular posts from this blog

Neisseria gonorrhoeae: Combating a Multidrug-Resistant Organism

Image
Neisseria gonorrhoeae: Combating a Multidrug-Resistant Organism: The worldwide spread of anti-toxin resistant sexually transmitted diseases (STD) has received increased consideration in the course of recent years from health institutes including the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC). In this post we will give a background marked by multidrug-safe Neisseria gonorrhoeae taken after by a depiction of the test techniques clinical labs are utilizing to decide the antimicrobial susceptibilities of N. gonorrhoeae isolates. About Gonorrhea Gonorrhea is a worldwide widespread disease caused by N. gonorrhoeae, a Gram-negative bacterium. As per CDC, roughly 470,000 new gonorrheal diseases were accounted for. Notwithstanding, on the grounds that numerous cases are asymptomatic, and consequently unreported, it is evaluated that there are roughly 820,000 new cases every year. Furthermore, it is assessed that 246,000 of these cases conv
Read more

The antibiotic that is active against drug-resistant tuberculosis:

Image
The antibiotic that is active against drug-resistant tuberculosis:  A naturally occurring antibiotic called kanglemycin A is effective against Mycobacterium tuberculosis, the bacteria that cause tuberculosis, even in drug-resistant strains, according to an international team of researchers who used chemistry, molecular biology, microbiology, and X-ray crystallography to show how the compound maintains its activity.  The compound, kanglemycin A, is related to the antibiotic rifampicin, according to Katsuhiko Murakami, professor of biochemistry and molecular biology at Penn State and one of leaders of the project. "Rifampicin is already part of the cocktail of antibiotics used to treat tuberculosis, but many strains of the tuberculosis-causing bacteria have developed resistance to it," Murakami said. "Tuberculosis is the leading cause of death by infectious disease worldwide," said Murakami. "Development of rifampicin resistance in M. tuberculosis has m
Read more

A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study by University of Alberta scientists. The next step is to develop a drug.

Image
A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study by University of Alberta scientists. The next step is to develop a drug... Another and promising class of synthetic mixes has the noteworthy potential for treating Zika disease and respiratory syncytial infection, or RSV, according to another examination by University of Alberta scientists. The accompanying stage is to develop a medication. "This is both a wonderful scientific discovery and something that can possibly emphatically influence worldwide wellbeing as well as the economy of Canada," said Fred West, professor in the Department of Chemistry who led the new discovery along with David Marchant. The compound is alike isatisine A which is an antiviral compound usually found in traditional Chinese herbal medicine. Hobman is a professor of cell biology and a specialist in the Zika virus, a pathogen that can
Read more